Results 201 to 210 of about 543,609 (231)

Revisiting the Role of Serotonin in Attention-Deficit Hyperactivity Disorder: New Insights from Preclinical and Clinical Studies. [PDF]

Clin Drug Investig
Solomon MB, Yegla B, Newcorn JH, Maletic V, Rubin J, Robbins TW.   +5 more
europepmc   +1 more source

The evolving burden of drug use disorders: a comprehensive epidemiological analysis from the 2021 Global Burden of Disease study. [PDF]

Front Psychiatry
Liu Y, Zhang N, Ren W, Lv X, Ran S, Tan X, Zhao Q.   +6 more
europepmc   +1 more source

Comparison of serious adverse effects of methylphenidate, atomoxetine and amphetamine in the treatment of ADHD: an adverse event analysis based on the FAERS database. [PDF]

BMC Pharmacol Toxicol
Wu L, Zhao D, Lan Y, Jin L, Yang L.
europepmc   +1 more source

Neuroendocrinology meets addiction: Emerging pharmacotherapies on the horizon. [PDF]

J Intern Med
Loften A, Farokhnia M, Vendruscolo LF, Leggio L.   +3 more
europepmc   +1 more source

Striatal transcriptomic alterations immediately after short-term abstinence from methamphetamine self-administration in rats. [PDF]

Mol Brain
Jang WJ, Song SH, Son T, Ryu IS, Jung JH, Lee S, Jeong CH.   +6 more
europepmc   +1 more source

Amphetamines: a current epidemic. [PDF]

Front Psychiatry
Miller N.
europepmc   +1 more source

Role of alpha-synuclein in the regulation of dopamine neurotransmission in the striatum [PDF]

Chadchankar, Heramb
core  

Use of Naltrexone for Patients With Stimulant Use Disorder in Malaysia: Protocol for a Retrospective Cohort Study.

JMIR Res Protoc
Muhamad NA, Ma'amor NH, Muhamad Rasat MA, Tengku Baharudin Shah TPN, Rosli '', Leman FN, Jamalluddin NH, Misnan NS, Chemi N, Abdullah N, Ibrahim N, My Addiction Study group.   +11 more
europepmc   +1 more source